MétaCan
Menu
Back to cohort
Record W2079429547 · doi:10.1136/ebm.14.4.101

What kind of randomised trials do patients and clinicians need?

2009· article· en· W2079429547 on OpenAlexaff
Merrick Zwarenstein, Shaun Treweek

Bibliographic record

VenueEvidence-Based Medicine · 2009
Typearticle
Languageen
FieldMedicine
TopicCerebrovascular and Carotid Artery Diseases
Canadian institutionsHealth Sciences CentreSunnybrook Health Science Centre
Fundersnot available
KeywordsMedicineIntensive care medicine

Abstract

fetched live from OpenAlex

In 1967 Daniel Schwartz and Joseph Lellouch1 argued that there are 2 kinds of randomised controlled trials (RCTs) embodying radically different attitudes to evaluation of treatment. They named these trials “pragmatic” and “explanatory” and stated that these 2 attitudes require different approaches to the design of an RCT. The pragmatic attitude seeks to directly inform real-world decisions among alternative treatments, and Schwartz and Lellouch show that this purpose is satisfied in trials that test feasible interventions on typical patients in common settings, with usual care as the comparator, to widen real-world applicability. The explanatory attitude, in contrast, is directed to understanding a biological process by testing the hypothesis that the specified biological response is explained by exposure to a particular treatment. Tight restrictions on eligible participants, intense and closely monitored treatment, inactive control interventions (such as placebo), and an idealised healthcare setting maximise the comparison between intervention and control groups and increase the ability to test this kind of hypothesis. What attitude to RCT design is most useful for patients and clinicians? Clearly, the trial has to ask an important question that is relevant to some aspect of the care clinicians provide to their patients. The clinicians and patients in the trial should resemble the clinicians who are reading the trial report and the patients they typically treat. The intervention being evaluated in the trial should be deliverable by the clinician, and the outcome being used to judge whether the intervention is effective has to be something that the clinician and his or her patients recognise as being worth influencing. In short, the trial has to be applicable, or have what is often called external validity.2 Consider the NASCET trial.3 It asked the following question: among patients with symptomatic 70–99% stenosis of a carotid …

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Direct model labels (unvalidated)

Per-model category and study-design labels from the labeling rounds. They are machine output, unvalidated, and the disagreement between models ships as data. No study design here is MEDLINE-validated yet.

Model armCategoriesStudy designConfidence
gemmaMetaresearch
Domain: Methods · Genre: Empirical
About the Canadian research system: no · About a Canadian topic: no
Not applicablelow
gptMetaresearch
Domain: Methods · Genre: Commentary
About the Canadian research system: no · About a Canadian topic: no
Theoretical or conceptuallow
models splitAgreement compares identical category sets and study designs across arms.

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.475
metaresearch head score (Gemma)0.755
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesMetaresearch
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Qualitative · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.525
Threshold uncertainty score0.647

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.4750.755
Meta-epidemiology (narrow)0.0030.004
Meta-epidemiology (broad)0.0240.007
Bibliometrics0.0140.011
Science and technology studies0.0060.043
Scholarly communication0.0330.086
Open science0.0130.013
Research integrity0.0570.034
Insufficient payload (model declined to judge)0.0210.016

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.069
GPT teacher head0.356
Teacher spread0.287 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Labeled directly by 2 models reading the full record.

Metaresearch

The models disagree on parts of this classification; every voice is preserved in the section at the end of the page.

Study designNot applicable · Theoretical or conceptual
DomainMethods
GenreEmpirical · Commentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations39
Published2009
Admission routes1
Has abstractyes

Explore more

Same venueEvidence-Based MedicineSame topicCerebrovascular and Carotid Artery DiseasesCategoryMetaresearchFrench-language works237,207